Status:
COMPLETED
Low-grade Inflammation and Gut Symptoms From A2 and Hydrolyses A1 Milk
Lead Sponsor:
University of Turku
Conditions:
Milk Intolerance
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of this study is to reveal how different forms of milk casein, lactose and moderate breakdown of proteins affect the symptoms that may arise from milk and markers of inflammation in volunteers...
Eligibility Criteria
Inclusion
- Perceive disturbing gut symptoms from regular milk
- Commits to the research diet for the whole research period
- Age: 18-65
- BMI: 18.5-30
- Healthy (normal kidney, liver and thyroid function and self-reported)
Exclusion
- Milk allergy
- Regular medication (other than contraceptives) or medication affecting the gut
- Recent course of antibiotics (\< 3 months prior the study)
- Pregnancy or lactation
- Diagnosed bowel disease
Key Trial Info
Start Date :
May 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2023
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT05305391
Start Date
May 18 2022
End Date
March 3 2023
Last Update
March 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Food Chemistry and Food Development, Department of Life Technologies, University of Turku
Turku, Finland, 20500